From Yahoo Finance: 2025-06-12 09:15:00

CERo Therapeutics (CERO) will undergo a one-for-twenty reverse stock split of its common stock on June 13, 2025. The split will reduce outstanding shares from 10,321,839 to 516,092. The company’s Common Stock will trade on a split-adjusted basis on The Nasdaq Capital Market. CUSIP number 71902K402 will be assigned post-split.



Read more at Yahoo Finance: Cero Therapeutics announces 1-for-20 reverse stock split